Fate Therapeutics Inc (FATE)
4.085
0.00 (0.00%)
USD |
NASDAQ |
May 02, 16:00
4.085
0.00 (0.00%)
After-Hours: 16:55
Fate Therapeutics Cash from Operations (TTM): -132.26M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -132.26M |
September 30, 2023 | -171.02M |
June 30, 2023 | -187.79M |
March 31, 2023 | -212.46M |
December 31, 2022 | -248.21M |
September 30, 2022 | -243.11M |
June 30, 2022 | -221.44M |
March 31, 2022 | -200.39M |
December 31, 2021 | -162.87M |
September 30, 2021 | -113.24M |
June 30, 2021 | -110.60M |
March 31, 2021 | -39.65M |
December 31, 2020 | -39.23M |
September 30, 2020 | -44.10M |
June 30, 2020 | -33.20M |
March 31, 2020 | -92.36M |
December 31, 2019 | -83.18M |
September 30, 2019 | -68.66M |
June 30, 2019 | -52.38M |
March 31, 2019 | -43.59M |
December 31, 2018 | -38.65M |
Date | Value |
---|---|
September 30, 2018 | -38.35M |
June 30, 2018 | -44.56M |
March 31, 2018 | -41.91M |
December 31, 2017 | -36.82M |
September 30, 2017 | -33.65M |
June 30, 2017 | -31.39M |
March 31, 2017 | -30.03M |
December 31, 2016 | -29.82M |
September 30, 2016 | -29.24M |
June 30, 2016 | -28.86M |
March 31, 2016 | -19.27M |
December 31, 2015 | -18.40M |
September 30, 2015 | -17.58M |
June 30, 2015 | -15.97M |
March 31, 2015 | -23.54M |
December 31, 2014 | -22.42M |
September 30, 2014 | -20.84M |
June 30, 2014 | -18.79M |
March 31, 2014 | -16.70M |
December 31, 2013 | -15.37M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-248.21M
Minimum
Dec 2022
-33.20M
Maximum
Jun 2020
-129.27M
Average
-113.24M
Median
Sep 2021
Cash from Operations (TTM) Benchmarks
Amicus Therapeutics Inc | -69.09M |
Regeneron Pharmaceuticals Inc | 4.594B |
Sarepta Therapeutics Inc | -500.99M |
ADMA Biologics Inc | 8.80M |
Ocular Therapeutix Inc | -70.23M |